PedAM

Pediatric Disease Annotations & Medicines

Disease	cystic fibrosis
Symptom	C0876973\|pulmonary infection
Sentences	20
PubMedID- 19805554	The results of the study show that the high concentrations of levofloxacin readily achievable in the lung following aerosol delivery may be useful for the management of pulmonary infections in patients with cystic fibrosis.
PubMedID- 24031589	Pseudomonas aeruginosa is a common cause of chronic pulmonary infection in patients with cystic fibrosis (cf).
PubMedID- 21395432	Abstract at present, the only approved inhaled antipseudomonal antibiotics for chronic pulmonary infections in patients with cystic fibrosis (cf) are nebulized solutions.
PubMedID- 23030647	During the last decades it has emerged as a cause of chronic pulmonary infection in patients with cystic fibrosis (cf).
PubMedID- 26356298	A group of 17 closely related species, designated b. cepacia complex organisms, cause pulmonary infections primarily in patients with cystic fibrosis .
PubMedID- 24637508	Aeruginosa is an opportunistic bacterial pathogen which establishes chronic pulmonary infections in patients with cystic fibrosis (cf).
PubMedID- 21750293	Context: early pulmonary infection in children with cystic fibrosis leads to increased morbidity and mortality.
PubMedID- 24489509	Treatment of pseudomonas and staphylococcus bronchopulmonary infection in patients with cystic fibrosis.
PubMedID- 20625718	Aeruginosa even in mature biofilms and cationic steroid antibiotics can thus be considered as potential candidates for the treatment of chronic pulmonary infections of patients with cystic fibrosis.
PubMedID- 25741986	Background: the antibiotics used to treat pulmonary infections in people with cystic fibrosis are typically chosen based on the results of antimicrobial susceptibility testing performed on bacteria traditionally grown in a planktonic mode (grown in a liquid).
PubMedID- 21991261	For example, p. aeruginosa isolates obtained from chronic pulmonary infections of patients with cystic fibrosis (cf) are often mucoid.
PubMedID- 25717335	Burkholderia scvs are associated with worse patient prognoses during pulmonary infections of persons with cystic fibrosis (cf) (haussler et al., 2003; silva et al., 2011), and correlate with higher biofilm productivity in our laboratory model (poltak and cooper, 2011).
PubMedID- 23943728	Background: the paranasal sinuses can be a bacterial reservoir for pulmonary infections in patients with cystic fibrosis (cf) methodology: in this prospective, non-randomised, uncontrolled, intervention cohort study, the clinical effect of sinus surgery followed by two weeks` intravenous antibiotics, 6 months` antibiotic nasal irrigations was assessed in 106 cf patients.
PubMedID- 22683550	P. aeruginosa is also responsible for pulmonary infection of patients with cystic fibrosis .
PubMedID- 22551926	Burkholderia cepacia complex (bcc) is a group of 17 closely related bacterial species that can cause pulmonary infection in patients with cystic fibrosis (cf).
PubMedID- 26187366	Burkholderia cenocepacia and other members of the burkholderia cepacia complex (bcc) are highly multidrug-resistant bacteria that cause severe pulmonary infections in patients with cystic fibrosis.
PubMedID- 24671511	Scientific reports suggest p. aeruginosa as the most important pathogen and causal agent of chronic pulmonary infections in patients with cystic fibrosis, which leads to gradual and eventually fatal decline in pulmonary function (govan and deretic 1996).
PubMedID- 25118167	Methicillin-resistant staphylococcus aureus (mrsa) causes chronic pulmonary infections in patients with cystic fibrosis (cf).
PubMedID- 24201191	Mycobacterium abscessus is a rapidly growing mycobacterium and an emerging human pathogen causing pulmonary infections, especially in patients with cystic fibrosis and other underlying lung disorders (1).
PubMedID- 23658631	It is particularly prominent as a pathogen in broncho-pulmonary infections in patients with cystic fibrosis and chronic lung disorders .

Page: 1